Recent Advances in Cancer Stem Cell

Cancer stem cells are one of the causes for the relapse of cancer cells and metastasis. They have drug confrontation in contradiction of most chemotherapeutic agents. Cancer stem cells are also liable for tumor cell heterogeneity and cause negligible residual disease. In order to attain whole deterioration of tumors, cscs have to be targeted. Current developments in immunotherapies have shown promising outcomes in preserving cancer, which are also relevant to target Cancer stem cells. Cscs express immune indicators and display precise immune appearances in numerous cancers, which can be used in immunotherapies to mark cscs in the tumor microenvironment. Lately, numerous policies have been used to target cscs. Adaptive T-cells, dendritic cell (DC)-based vaccines, oncotic viruses, immune checkpoint inhibitors, and combination therapies are now being used to target cscs.

 

 

 

 

 

<p justify;"="">

    Related Conference of Recent Advances in Cancer Stem Cell

    April 17-18, 2024

    14th International Conference on Chemistry Meeting

    Paris, France
    June 25-26, 2024

    13th World Congress on Chromatography

    Toronto, Canada
    August 22-23, 2024

    16th International Conference on Clinical Chemistry

    Berlin, Germany
    December 18-19, 2024

    4th International Conference on Petrochemistry and Natural Gas

    Amsterdam, Netherlands

    Recent Advances in Cancer Stem Cell Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in